Now is Endocrinología, Diabetes y Nutrición (English ed.). More information
Endocrinología y Nutrición is the official publication of the Spanish Society of Endocrinology and Nutrition (SEEN) and the Diabetes Spanish Society (SED) . It is the best journal to keep up to date with endocrine pathophysiology both in the clinical and in the research field. It publishes the best original articles of large research institutions, as well as prestigious reviews.Indexed in:
Index Medicus/MEDLINE, Excerpta Medica/EMBASE, SCOPUS, Science Citation Index Expanded, Journal Citation Reports/Science Edition, IBECS
See moreFollow us:
Impact factor
The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.
© Clarivate Analytics, Journal Citation Reports 2022
Impact factor 2017
1.268
SJR
SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.
See moreSJR 2017
0.28
SNIP
SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.
See moreSNIP 2017
0.383
View more metrics
Discontinued publication
Hide
Journal Information
Special content about coronavirus SARS-CoV-2 (COVID-19) in Endocrinología y Nutrición (English Edition)
Gut microbiota and type 2 diabetes mellitus
Araceli Muñoz-Garach, Cristina Diaz-Perdigones, Francisco J. Tinahones
10.1016/j.endoen.2016.07.004
Endocrinol Nutr 2016;63:560-8
Full text access
Healthcare costs of people with type 2 diabetes mellitus in the Basque Country (Spain)
Roberto Nuño-Solinís, Edurne Alonso-Morán, Jose M. Arteagoitia Axpe, Patxi Ezkurra Loiola, Juan F. Orueta, Sonia Gaztambide
10.1016/j.endoen.2016.11.002
Endocrinol Nutr 2016;63:543-50
Full text access
Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus
Antoni Sicras-Mainar, Ruth Navarro-Artieda, Raúl Morano, Lucía Ruíz
10.1016/j.endoen.2016.07.002
Endocrinol Nutr 2016;63:527-35
Full text access
Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus
Irene Romera, Francisco Javier Ampudia-Blasco, Antonio Pérez, Bernat Ariño, Egon Pfarr, Sanja Giljanovic Kis, Ebrahim Naderali
10.1016/j.endoen.2016.11.001
Endocrinol Nutr 2016;63:519-26
Full text access
The diabetic paradox: Bone mineral density and fracture in type 2 diabetes
Sonsoles Botella Martínez, Nerea Varo Cenarruzabeitia, Javier Escalada San Martin, Amparo Calleja Canelas
10.1016/j.endoen.2016.10.010
Endocrinol Nutr 2016;63:495-501
Full text access
Clinical status of a cohort of patients with type 1 diabetes diagnosed more than 2 decades before. Results of a specific clinical follow-up program
Antonio J. Amor, Maria Cabrer, Marga Giménez, Irene Vinagre, Emilio Ortega, Ignacio Conget
10.1016/j.endoen.2016.08.002
Endocrinol Nutr 2016;63:339-44
Full text access
Diabetes knowledge among Greek Type 2 Diabetes Mellitus patients
Dimitrios Poulimeneas, Maria G. Grammatikopoulou, Vasiliki Bougioukli, Parthena Iosifidou, Maria F. Vasiloglou, Maria-Assimina Gerama, Dimitrios Mitsos, Ioanna Chrysanthakopoulou, Maria Tsigga, Kyriakos Kazakos
10.1016/j.endoen.2016.09.003
Endocrinol Nutr 2016;63:320-6
Full text access
Association between information sources and level of knowledge about diabetes in patients with type 2 diabetes
Katherine Cántaro, Jimena A. Jara, Marco Taboada, Percy Mayta-Tristán
10.1016/j.endoen.2016.05.007
Endocrinol Nutr 2016;63:202-11
Full text access
Prevalence of impaired fasting glucose and type 1 and 2 diabetes mellitus in a large nationwide working population in Spain
Jesús Reviriego, Luis Alberto Vázquez, Albert Goday, Martha Cabrera, María Teresa García-Margallo, Eva Calvo
10.1016/j.endoen.2016.04.007
Endocrinol Nutr 2016;63:157-63
Full text access
Differences in clinical and biological characteristics and prevalence of chronic complications related to aging in patients with type 2 diabetes
María Luisa Basanta-Alario, Jordi Ferri, Miguel Civera, Sergio Martínez-Hervás, Juan Francisco Ascaso, José Tomás Real
10.1016/j.endoen.2015.10.011
Endocrinol Nutr 2016;63:79-86
Full text access
Special content about COVID-19
- Gut microbiota and type 2 diabetes mellitus
- Healthcare costs of people with type 2 diabetes mellitus in the Basque Country (Spain)
- Use of healthcare resources and costs associated to the start of treatment with injectable drugs in patients with type 2 diabetes mellitus
- Efficacy and safety of empagliflozin in combination with other oral hypoglycemic agents in patients with type 2 diabetes mellitus
Publication History